NASDAQ: RLYB
Rallybio Revenue

Rallybio revenue was $636.00k for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $38.0k, down 87.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RLYB annual revenue was $636.0k, with Infinity% growth year-over-year.

RLYB revenue history

Current Revenue
$636.0k
Current Earnings
-$57.8M
Current Profit Margin
-9,084.1%

Be the first to know when RLYB announces revenue.

RLYB Revenue History By Year

RLYB Yearly RevenueRLYB RevenueRLYB ChangeRLYB Revenue Growth
2024-12-31$636.00kN/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A

1 of 1

Rallybio Revenue FAQ

What was RLYB's revenue last quarter?

Rallybio (NASDAQ: RLYB) reported Q4 2024 revenue of $38.00 thousand up Infinity% year over year. In the same quarter last year, Rallybio's revenue was $0.00.

What was Rallybio's revenue in 2024?

Rallybio's annual revenue for the twelve months ending Dec 31, 2024 was $636.00 thousand, a Infinity% increase year over year.

How much does Rallybio make in a day?

Based on Rallybio annual revenue for the past five years, RLYB makes an average of $348.49 per day.

What was Rallybio's annual revenue growth in the past year?

As of Q2 2025, Rallybio's revenue has grown null year over year. Rallybio's revenue in the past year totaled $636.00 thousand.

How much does Rallybio make in a year?

Rallybio's revenue by year for the past five years is:
  • Rallybio's revenue for the twelve months ending Dec 31, 2024 was $636.00 thousand, a Infinity% increase year over year.
  • Rallybio's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Rallybio's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Rallybio's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Rallybio's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.